Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Harbour Antibodies Partners with Abveris, a Boston Drug Discovery CRO

publication date: Jul 16, 2019

Harbour Antibodies, the Dutch drug discovery subsidiary of Harbour BioMed, partnered with Boston's Abveris to offer its fully-human antibody discovery services together with Abveris' therapeutic antibody discovery services. Under a Co-Offering Agreement, Averis will be able to offer clients a low-upfront evaluation fee and pre-negotiated commercial terms. This will allow Abveris clients to consider the Harbour's H2L2 human transgenic mouse technology before committing to a commercial license. Headquartered in Boston, Harbour Bio has operations in Shanghai and Suzhou. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital